COVID-19 and immune checkpoint inhibitors: initial considerations

COVID-19 infections are characterized by inflammation of the lungs and other organs that ranges from mild and asymptomatic to fulminant and fatal. Patients who are immunocompromised and those with cardiopulmonary comorbidities appear to be particularly afflicted by this illness. During pandemic cond...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Sullivan, Ryan J, Johnson, Douglas B, Rini, Brian I, Neilan, Tomas G, Lovly, Christine M, Moslehi, Javid J, Reynolds, Kerry L
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Commentary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7246104/
https://ncbi.nlm.nih.gov/pubmed/32434790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000933
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados